Envoy Medical (COCH) Long-Term Deferred Tax (2021 - 2023)

Envoy Medical (COCH) has 3 years of Long-Term Deferred Tax data on file, last reported at $41.2 million in Q4 2023.

• For the quarter ending Q4 2023, Long-Term Deferred Tax rose 2.13% year-over-year to $41.2 million; the trailing twelve-month figure through Dec 2023 stood at $41.2 million (up 2.13% YoY), and the FY2023 full-year result was $41.2 million, up 2.13% from the prior year.
• Long-Term Deferred Tax rose to $41.2 million in Q4 2023, from $40.3 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $41.2 million in Q4 2023 to a low of $7910.0 in Q4 2021.
• A 3-year average of $27.2 million and a median of $40.3 million in 2022 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax soared 509331.1% in 2022 and rose 2.13% in 2023, its largest moves.
• Tracing COCH's Long-Term Deferred Tax over 3 years: stood at $7910.0 in 2021, then soared by 509331.1% to $40.3 million in 2022, then gained by 2.13% to $41.2 million in 2023.
• Business Quant data shows COCH's Long-Term Deferred Tax at $41.2 million in Q4 2023, $40.3 million in Q4 2022, and $7910.0 in Q4 2021.